Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease

Authors

  • Federico Iovino,

    1. Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author
  • Matthijs C. Brouwer,

    1. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA),, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Search for more papers by this author
  • Diederik van de Beek,

    1. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA),, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Search for more papers by this author
  • Grietje Molema,

    1. Department of Pathology & Medical Biology, Medical Biology Section, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author
  • Jetta J. E. Bijlsma

    Corresponding author
    • Department of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Search for more papers by this author

For correspondence. E-mail j.j.e.bijlsma@umcg.nl; Tel. (+31) 50 3615239; Fax (+31) 50 3619106.

Summary

Streptococcus pneumoniae (the pneumococcus) is an opportunistic human pathogen, which causes serious invasive disease such as pneumonia, bacteraemia and meningitis. The interaction of the bacteria with host receptors precedes the development of invasive disease. One host receptor implicated in pneumococcal adhesion to, invasion of and ultimately translocation of cell layers is the platelet-activating factor receptor (PAFR). PAFR is a G-protein coupled receptor which binds PAF, a potent phospholipid activator involved in many leucocyte functions, platelet aggregation and inflammation. PAFR has been proposed to bind S. pneumoniae and as such facilitate adhesion to, uptake by and transcytosis of endothelial cells leading to invasive disease. However, there is a shortage of biochemical data supporting direct interaction between PAFR and the bacteria, in addition to conflicting data on its role in development of invasive pneumococcal disease (IPD). In this review, we will discuss current literature on PAFR and S. pneumoniae and other pathogens,including data concerning human PAFR genetic variation related to IPD clinical aspects, to shed light on the importance of PAFR in IPD. Clarification of the role of this receptor in IPD development has the potential to enable the development of novel therapeutic strategies for treating pneumococcal disease by interfering with the PAFR.

Ancillary